🔗 Share this article

While America proceeds with historic revisions to its vaccination recommendations, one figure has emerged somewhat surprisingly: Tracy Beth Høeg, a US-based physician and public health researcher who initially gained attention by casting doubt on COVID-19 vaccines in the global health crisis and has zeroed in on alleged fatalities after COVID-19 vaccination in her short time at the FDA.

Scheduled Overhauls to Childhood Vaccine Program

Health officials were set to unveil radical changes to the childhood vaccination calendar recently, bringing the US with the Danish vaccine program, according to reports – a substantial departure that would place the US out of alignment with a large portion of the world with insufficient data for improved outcomes. The announcement has been postponed until the next year.

In place of Vinay Prasad, Dr. Høeg is scheduled to present at the meeting. She was newly appointed temporary leader of the FDA’s CDER, the fifth person to run the office this year.

A Shift at the Regulatory Body

This interim role may indicate a tighter collaboration between the drug and vaccine branches as Høeg and Prasad solidify control at the FDA – and it points to a greater focus upon dismantling already-approved vaccines at the FDA.

Dr. Høeg has repeatedly called for ending certain childhood immunization guidelines in the US to become more similar to Denmark, a society with nationalized medicine and a number of inhabitants approximately the size of Wisconsin’s.

In her initial comments, she has kept her attention on vaccination policy – typically the responsibility of Prasad, chief of the FDA’s vaccine center – instead of pharmaceutical oversight.

Doubts Over Background

The appointee has little discernible background in drug development, oversight or leadership, which has been customary for past heads of the CBER. She has been employed at the FDA as a top consultant to the commissioner and CBER since earlier this year.

“She doesn’t seem to have any of the qualifications” for running the drug-regulation department, remarked Jonathan Howard. “She has not conducted a clinical trial. She is not versed in leading a sizeable institution. She lacks background in drug approvals.”

Past commissioners of the center would “understand laws and regulations and the research of drug development”, noted a former acting FDA commissioner. “Frankly, she doesn’t have the sort of resume that former directors who ran the center have had.”

This division has an enormous range of responsibilities at the FDA, Woodcock stated.

“Everybody just pays attention on the novel medication approvals, but the off-patent medication office clears thousands of generic drugs. There’s a biosimilars division, OTC medication office and so forth, and all of those must be managed,” Dr. Woodcock explained. “The responsibility you neglect, that’s the thing that I always told people is going to cause problems.”

Furthermore, a major administrative element to the job, which oversees more than 5,000 employees. “It is a massive leadership role, if you execute it properly,” the former official said.

Response and Contentious Programs

In response to concerns about Dr. Høeg's qualifications and whether this assignment signifies increased cooperation among agency officials on vaccines, a spokesperson responded that the “concerns stem from inaccurate presumptions”.

“Her resume aligns with the responsibilities of her role,” the official stated, pointing to the time Dr. Høeg spent advising the FDA commissioner on “pharmaceutical safety and oversight research, including computerized risk analysis and immunization monitoring”.

As the temporary head, Høeg inherits the agency head's recently launched expedited review system, a disputed rapid medication authorization process that apparently troubled her former heads. “How are these therapies being chosen for this fast-track system? Who takes the decisions?” Howard said. “There’s a lot of confidentiality happening at the FDA right now.”

In general, he said, “the Food and Drug Administration looks to be trending towards laxer oversight of most medications, except for vaccines.”

Established Track Record on Vaccines

Regarding vaccines, Høeg has a more documented, if concerning, past, some experts observe. She released a research paper using unverified crowd-sourced reports to estimate the frequency of myocarditis after Covid vaccination. She counseled the Florida chief medical officer Joseph Ladapo, who reportedly have altered data to suggest COVID-19 vaccinations are pose a greater threat than they are.

Included in her “policy goals” for the new government encompassed revising regulations for novel immunizations and discontinuing “non-essential” immunizations, she said after the election on a podcast. At the agency, Dr. Høeg has according to sources proposed excluding young men from receiving Covid vaccines.

“She’s an all-around ideologue who commences with her beliefs and works backwards to retrofit the data in a highly misleading, dishonest manner,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Høeg aligned with other skeptics, {like|